Publications by:
Kelli P.A. MacDonald
Also publishes as (Kelli Macdonald)
Up a level |
Zeng, Bijun, Middelberg, Anton P.J., Gemiarto, Adrian, Macdonald, Kelli, Baxter, Alan G., Talekar, Meghna, Moi, Davide, Tullett, Kirsteen M., Caminschi, Irina, Lahoud, Mireille H., Mazzieri, Roberta, Dolcetti, Riccardo, and Thomas, Ranjeny (2018) Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. Journal of Clinical Investigation, 128 (5). pp. 1971-1984.
O’Sullivan, Brendan J., Pai, Saparna, Street, Shayna, An, Xiayou, MacDonald, Kelli P.A., Wong, Michele, Strutton, Geoffrey, Gerondakis, Steve, Steptoe, Raymond J., Fazekas de St. Groth, Barbara, Hill, Geoffrey R., and Thomas, Ranjeny (2011) Immunotherapy with costimulatory dendritic cells to control autoimmune inflammation. Journal of Immunology, 187 (8). pp. 4018-4030.
Markey, Kate A., Burman, Angela C., Banovic, Tatjana, Kuns, Rachel D., Raffelt, Neil C., Rowe, Vanessa, Olver, Stuart D., Don, Alistair L.J., Morris , Edward S., Pettit, Alison R., Wilson, Yana A., Robb, Renee J., Randall, Louise M., Korner, Heinrich, Engwerda, Christian R., Clouston, Andrew D., MacDonald, Kelli P.A., and Hill, Geoffrey R. (2010) Soluble lymphotoxin is an important effector molecule in GVHD and GVL. Blood, 115 (1). pp. 122-132.